2 results
Approved WMOPending
The aim of this pilot-study is to establish the potential efficacy of acute doses of 50 mgs D-cycloserine (DCS), a partial NMDA agonist, in accelerating and/or augmenting the effect of exposure and response prevention (ERP) in the treatment of…
Approved WMOCompleted
To determine the effect of botulinum toxin type A injections in stroke patients with stiff knee gait.